Mortality in preterm infants with respiratory distress syndrome treated with poractant alfa, calfactant or beractant: a retrospective study.

J Perinatol · 2013 · PMC3558698 · PMID 21886094

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significanceP =0.053so close (0.05 < p ≤ 0.1)

Beractant treatment was associated with a 37.0% increased mortality compared with poractant alfa, but the difference did not reach statistical significance (OR: 1.370, 95% CI: 0.996–1.885, P =0.053).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.